In February 2019, Kathy Vandebelt joined Oracle Health Sciences as Global Head of Clinical Innovation, bringing over 30 years of clinical research and field perspective to the table.
In this role, Kathy helps inform the product strategy to ensure solutions are aligned to deliver the most benefit to site staff and patients, and the most value to sponsors.
Building upon her own experience in the industry, Kathy gathered feedback from the field – study team members, site staff and patients – as well as validated industry trends with biopharma executives, through both primary and secondary research over the course of 2019.
What Kathy learned validated some positions, challenged others and introduced entirely new angles previously unknown. This years’ worth of work gathering, synthesizing and understanding the real challenges, opportunities and trends shaping the clinical trial environment is captured in this report. It is being shared in the spirit of “knowledge is power” – the more we, as a holistic community, understand the reality of the field in which we work, the better we can evolve to support and advance the pace of clinical research.